Lacosamide 51991-0349-06
- Manufacturer
- Breckenridge Pharmaceutical, Inc.
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CV
- Marketing Start
- March 18, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA204921
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lacosamide | 100 mg/1 |
Drug Class
Decreased Central Nervous System Disorganized Electrical Activity [PE]
Selected Package
51991-0349-06Selected60 TABLET, FILM COATED in 1 BOTTLE (51991-349-06)
Other packages for this product(1)
500 TABLET, FILM COATED in 1 BOTTLE (51991-349-05)